RenovaCare, Inc. Enters R&D Partnership with World Leading Charité

New York & Pittsburgh, PA – November 17, 2015 – RenovaCare, Inc. (OTCQB: RCAR), today announced a partnership to validate the science behind its groundbreaking technology for treatments of wounds, burns and other skin defects. The company’s research partner is Berlin-Brandenburg Center for Regenerative Therapies (BCRT), a translational research center at Charité – Universitätsmedizin Berlin,…

Featured On National Geographic

The SkinGun™ is profiled on National Geographic. Click here to watch the video at natgeo.com (opens in a new tab or window). RenovaCare’s patented SkinGun™ spray device is the world’s most advanced technology of its kind. As part of our groundbreaking CellMist™ System, it has shown in early clinical observations in the United States and…

RenovaCare, Inc. and StemCell Systems GmbH: Collaborators for Breakthrough Development

RenovaCare has joined forces with StemCell Systems GmbH, one of Germany’s leading firms in the field of technologies for regenerative medicine, to advance its CellMist™ System and SkinGun™ delivery device toward commercial release. StemCell Systems invents and engineers biomedical devices for regenerative medicine. Based in Berlin, Germany, their engineering services are geared toward providing innovation…